Literature DB >> 21713719

[Assessment of drug treatment in geriatrics with the new FORTA criteria].

H Frohnhofen1, C Michalek, M Wehling.   

Abstract

BACKGROUND: Multimorbidity in the elderly often leads to inappropriate and harmful polypharmacy. Various approaches have been used to prioritize components of drug treatment, especially as on negative lists like the Beers list. A new approach is the FORTA assessments system ( Fit f OR The Aged) in which drugs are graded as positive (A, should be given), intermediate (B or C), and negative (D should not be given).
METHODS: In this pilot study of 46 patients in a geriatric ward medication was assessed on admission and at discharge, using the FORTA criteria. All changes in the number of prescribed drugs, the distribution of FORTA criteria, and the number of drug interactions were recorded.
RESULTS: The use of FORTA resulted in a decrease in the total number of prescirbed drugs from 7.3 ± 2,9 to 6.7 ± 2,3 (p = 0.06), and an increase in positively assessed drugs (A / B) from 59 ± 20 to 77 ± 38 % (p < 0.01), as well as a decrease in negatively assessed drugs (D) from 7 ± 12 to 5 ± 9 % (p = 0.06). The number of drugs assessed as intermediate (C) did not change significantly. Under-treatment decreased from 65 to 39 % (p < 0.01), over-treatment from 65 % to 20 % (p < 0.01). The number of drug interactions decreased from 79 to 54 (p < 0.01).
CONCLUSION: This uncontrolled pilot study indicates that the FORTA criteria can be used in day-to-day clinical care: it describes the quality of changes in drug treatment in a geriatric ward in a plausible way. This study has provided basic uncontrolled data which should be validated in controlled studies comparing the quality of treatment with or without the use of the FORTA criteria. (DKRS-ID: DRKS00000531). © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21713719     DOI: 10.1055/s-0031-1281530

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  6 in total

Review 1.  [Polypharmacy and drug prescription in the elderly. Strategies for optimization].

Authors:  R Eckardt; E Steinhagen-Thiessen; S Kämpfe; N Buchmann
Journal:  Z Gerontol Geriatr       Date:  2014-06       Impact factor: 1.281

Review 2.  Inappropriate prescribing: a systematic overview of published assessment tools.

Authors:  Carole P Kaufmann; Regina Tremp; Kurt E Hersberger; Markus L Lampert
Journal:  Eur J Clin Pharmacol       Date:  2013-09-10       Impact factor: 2.953

3.  Effects of "Fit fOR The Aged" (FORTA) on pharmacotherapy and clinical endpoints--a pilot randomized controlled study.

Authors:  Carina Michalek; Martin Wehling; Jeanina Schlitzer; Helmut Frohnhofen
Journal:  Eur J Clin Pharmacol       Date:  2014-08-17       Impact factor: 2.953

4.  [Medication in the elderly : cognitive impairment by drugs].

Authors:  M Wehling
Journal:  Internist (Berl)       Date:  2012-10       Impact factor: 0.743

5.  Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly.

Authors:  Alexandra M Kuhn-Thiel; Christel Weiß; Martin Wehling
Journal:  Drugs Aging       Date:  2014-02       Impact factor: 3.923

6.  [Identification of polypharmacy-associated risks among nursing home residents].

Authors:  Michael Specka; Maria Groll; Norbert Scherbaum; Jens Wiltfang; Jens Benninghoff
Journal:  Z Gerontol Geriatr       Date:  2021-02-11       Impact factor: 1.281

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.